Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| World Cancer-treating Drugs Market Forecast 2017-2027 | ||
| By: PR Newswire Association LLC. - 20 Sep 2017 | Back to overview list |
|
LONDON, September 20, 2017 /PRNewswire/ -- Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period. The market reached $102bn in 2016, dominated by the immunotherapy segment which held 44.1% share of the market. (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg ) How this report will benefit you In this brand new 194-page report you will receive 110 tables and 101 figures - all unavailable elsewhere. The 194-page report provides clear detailed insight into the world cancer-treating drugs market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope • World cancer-treating drugs market forecasts from 2017-2027 • This report also breaks down the revenue forecast for the world cancer-treating drugs market by its leading segments: Each sector is analysed and revenue forecasts presented. • This report discusses and forecasts revenues of the top 25 anti-cancer drugs: • This report provides individual revenue forecasts to 2027 for these regional and national markets: • This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT). It also analyses social, technological, economic and political factors (STEP) that influence the cancer-treating drugs market • Our study discusses the selected leading companies that are the major players in the cancer-treating drugs market: The report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments. Visiongain's study is intended for anyone requiring commercial analyses for the world cancer-treating drugs market. You find data, trends and predictions. Buy our report today World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs. To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100 Or click on https://www.visiongain.com/Report/1995/World-Cancer-Treating-Drugs-Market-Forecast-2017-2027 List of Companies Mentioned in the Report AbbVie Active Biotech Advaxis Alchemia Allergan Amgen AmpImmune Argos Therapeutics ArQule AstraZeneca Barvarian Nordic Bayer Biothera BioXpress Therapeutics Boehringer Ingelheim Bristol-Myers Squibb Celator Pharmaceuticals Celgene Cephalon Clovis Oncology Cyclacel Daiichi Sankyo Dendreon Dr. Reddy's Laboratories Eisai Eli Lilly EMA Sanofi EMD Serono Galena Biopharma Gilead GSK Heat Biologics Immatics Biotechnologies Infinity Pharmaceuticals Inovio Pharmaceuticals Janssen Jennerex Biotherapeutics Jiangsu Hengrui Medicine Johnson & Johnson MedImmune Merck & Co. Merck KGaA Merck Sharpe and Dohme Merrimack Newlink Novartis OncoGenex Onyx Orion OSi Pharmaceuticals Petrov Institute of Oncology Pfizer Pharmacyclics Progen Pharmaceuticals Puma Biotechnology Roche Spectrum Pharmaceuticals Spirogen Sun Pharma Sunesis Pharmaceuticals Syndax Takeda Telomedix TESARO Teva Pharmaceuticals Tracon Pharma Transgene United Therapeutics Vaccinogen Viventia Biotech Xbiotech To see a report overview please email Sara Peerun on sara.peerun@visiongain.com SOURCE Visiongain Ltd 
|
||
|
|
||
 | Back to overview list | |
